Difference between revisions of "MEDICATION-MAGNESIUM"
From NeuroRehab.wiki
(Imported from text file) |
(Imported from text file) |
||
| Line 4: | Line 4: | ||
==Reference(s)== | ==Reference(s)== | ||
Gale, M., Grantham, H., Morley, P. and Parr, M. (2016). Advanced Life Support Level 1: 3rd Australian Edition. Australian Resuscitation Council. | Gale, M., Grantham, H., Morley, P. and Parr, M. (2016). Advanced Life Support Level 1: 3rd Australian Edition. Australian Resuscitation Council. | ||
American College Of Surgeons. Committee On Trauma (2012). ATLS : student course manual. Chicago, Ill.: American College Of Surgeons. | <br/>American College Of Surgeons. Committee On Trauma (2012). ATLS : student course manual. Chicago, Ill.: American College Of Surgeons. | ||
[[Category:Medication]] | [[Category:Medication]] | ||
[[Category:Advanced Life Support]] | [[Category:Advanced Life Support]] | ||
Revision as of 01:50, 17 December 2022
1. Important membrane stabilizer. Hypomagnesemia causes myocardial hyper-excitability, particularly in the presence of hypokalemia.
2. Causes of hypomagnesemia: diuresis, diarrhea, alcohol-abuse.
3. Indications: Torsade's de pointes, hypomagnesemia, hypokalemia, VF or VT refractory to DC shock, cardiac arrest A/W digoxin-toxicity.
4. SE: muscle weakness, paralysis, respiratory failure.
DOSAGE
5. 5-10 mmol bolus, infusion of 20 mmol over 4 hours.
Reference(s)
Gale, M., Grantham, H., Morley, P. and Parr, M. (2016). Advanced Life Support Level 1: 3rd Australian Edition. Australian Resuscitation Council.
American College Of Surgeons. Committee On Trauma (2012). ATLS : student course manual. Chicago, Ill.: American College Of Surgeons.
